---
title: Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
nct_id: NCT03319290
overall_status: UNKNOWN
sponsor: Data Collection Analysis Business Management
study_type: OBSERVATIONAL
primary_condition: Hereditary Cancer
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03319290.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03319290"
ct_last_update_post_date: 2019-01-23
last_seen_at: "2026-05-12T06:06:40.385Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies

**Official Title:** Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk Reducing, and Preventative Strategies Using BRCA2 and BRCA2 Genetic Testing

**NCT ID:** [NCT03319290](https://clinicaltrials.gov/study/NCT03319290)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 2000
- **Lead Sponsor:** Data Collection Analysis Business Management
- **Collaborators:** PAS Research Services
- **Conditions:** Hereditary Cancer
- **Start Date:** 2017-10-17
- **Completion Date:** 2020-10-17
- **CT.gov Last Update:** 2019-01-23

## Brief Summary

Observational study is to increase surveillance for breast and ovarian cancers, also to determine targeted risk-reducing and preventative strategies.

## Detailed Description

The general design of this study is collecting data and reviewing the Principal Investigators' (P.I.) Standard Operating Procedures (SOP) on BRCA testing and changes made to their specific SOP.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 65 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Must be a Medical Practitioner

  * Medical Doctor (MD)
  * Doctor of Osteopathic (DO)
  * Physician Assistant (PA)
  * Advanced Practice Registered Nurse (APRN)
  * Nurse Practitioner (NP)
* Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history

Exclusion Criteria:

* Government-funded insurance data cannot be included in the study.
```

## Interventions

- **BRCA1 and BRCA2** (GENETIC) — Genetic breast and ovarian cancer testing

## Primary Outcomes

- **Provider Structures and Processes** _(time frame: 36 months)_ — Plan of Care Changes due to BRCA testing. Provider based observational survey system on the health and well-being of patients and populations

## Locations (1)

- DCABM, Land O' Lakes, Florida, United States

## Recent Field Changes (last 30 days)

- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.dcabm|land o' lakes|florida|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03319290.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03319290*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*